Respiratory drug discovery, current developments and future challenges: Highlights from the Society of Medicines Research Symposium, held on June 14th, 2012 - Horsham, UK

Drugs of the Future

Volumn 37, Issue 8, 2012, Pages 619-625

  Collingwood, S P ^a   Coe, D ^b   Pryde, D ^c   Lock, R ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Histamine receptor antagonists; Inhaled therapies; Nanobodies; PI3Kdelta inhibitors; Respiratory disorders; Translational medicine

Indexed keywords

1 (5 CHLORO 2 INDOLYLCARBONYL) 4 METHYLPIPERAZINE; ALX 0171; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; GLUCOCORTICOID; GLYCOPYRRONIUM BROMIDE; HISTAMINE H4 RECEPTOR ANTAGONIST; INDACATEROL; INDAZOLE DERIVATIVE; LEBRIKIZUMAB; MONOCLONAL ANTIBODY; MUSCARINIC RECEPTOR BLOCKING AGENT; PALIVIZUMAB; PF 3306138; PF 3893787; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE DELTA INHIBITOR; PLACEBO; SALMETEROL; TIOTROPIUM BROMIDE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ANTIVIRAL ACTIVITY; ASTHMA; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG FORMULATION; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG RESEARCH; ENZYME INHIBITION; HUMAN; LUNG FUNCTION TEST; MEDICAL SOCIETY; MUSCULOSKELETAL DISEASE; NONHUMAN; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT DISEASE; TREATMENT RESPONSE; UNITED KINGDOM;

EID: 84952988075     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2012.037.08.1854604     Document Type: Conference Paper

References (17)

1. Halwani, R., Al-Muhsen, S., Hamid, Q. Airway remodeling in asthma. Curr Opin Pharmacol 2010, 10(3): 236-45.
2. McDonough, J.E., Yuan, R., Suzuki, M. et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011, 365(17): 1567-75.
3. Farah, C.S., King, G.G., Brown, N.J. et al. The role of the small airways in the clinical expression of asthma in adults. J Allergy Clin Immunol 2012, 129(2): 381-7.
4. Warheit, D.B., Hansen, J.F., Yuen, I.S., Kelly, D.P., Snajdr, S.I., Hartsky, M.A. Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation. Toxicol Appl Pharmacol 1997, 145(1): 10-22. (Pubitemid 27294765)
5. Lee, K.P., Trochimowicz, H.J., Reinhardt, C.F. Pulmonary response of rats exposed to titanium dioxide (TiO2) by inhalation for two years. Toxicol Appl Pharmacol 1985, 79(2): 179-92. (Pubitemid 15013722)
6. Jones, R.M., Neef, N. Interpretation and prediction of inhaled drug particle accumulation in the lung and its associated toxicity. Xenobiotica 2012, 42(1): 86-93.
7. Jones, R.M., Harrison, A. A new methodology for predicting human pharmacokinetics for inhaled drugs from orotracheal pharmacokinetic data in rats. Xenobiotica 2012, 42(1): 75-85.
8. Disse, B., Reichl, R., Speck, G., Traunecker, W., Ludwig Rominger, K.L., Hammer, R. Ba 679 BR, a novel long-acting anticholinergic bronchodilator. Life Sci 1993, 52(5-6): 537-44.
9. Sykes, D.A., Dowling, M.R., Leighton-Davies, J.L. et al. The influence of receptor kinetics on the onset, duration of action, and the therapeutic Index of NVA237 and tiotropium. In press.
10. Vauquelin, G., Charlton, S.J. Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action. Br J Pharmacol 2010, 161(3): 488-508.
11. Lombardi, D., Cuenoud, B., Krämer, S.D. Lipid membrane interactions of indacaterol and salmeterol: Do they influence their pharmacological properties? Eur J Pharm Sci 2009, 38(5): 533-47.
12. Corren, J., Lemanske, R.F., Hanania, N.A. et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011, 365(12): 1088-98.
13. Hershey, G.K.K. IL-13 receptors and signalling pathways: An evolving web. J Allergy Clin Immunol 2003, 111(4): 677-90.
14. Sidhu, S.S., Yuan, S., Innes, A.L. et al. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci U S A 2010, 107(32): 14170-5.
15. Woodruff, P.G., Modrek, B., Choy D.F. et al. T-Helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009, 180(5): 388-95 [Erratum: Am J Respir Crit Care Med 2009, 180(8): 796].
16. McClintock, D., Corren, J., Hanania, N.A. et al. Lebrikizumab, an anti-IL-13 monoclonal antibody, reduces severe asthma exacerbations over 32 weeks in adults with inadequately controlled asthma. Am J Respir Crit Care Med [Int Conf Am Thorac Soc (May 18-23, San Francisco) 2012] 2012, 185: Abst 813.
17. Rowan, W.C., Smith, J.L., Affleck, K., Amour, A. Targeting phosphoinositide 3-kinase ä for allergic asthma. Biochem Soc Trans 2012, 40(1): 240-5.